Phase I, double-blind, randomised, crossover trial of Linjeta in type 1 diabetes mellitus

Trial Profile

Phase I, double-blind, randomised, crossover trial of Linjeta in type 1 diabetes mellitus

Completed
Phase of Trial: Phase I

Latest Information Update: 28 Jun 2011

At a glance

  • Drugs Insulin; Insulin lispro
  • Indications Type 1 diabetes mellitus
  • Focus Pharmacodynamics; Pharmacokinetics
  • Sponsors Biodel
  • Most Recent Events

    • 28 Jun 2011 Results presented at the 71st Annual Scientific Sessions of the American Diabetes Association.
    • 13 Nov 2010 Results were presented at the 10th Annual Diabetes Technology Meeting, according to a Biodel media release.
    • 21 Sep 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top